e-Therapeutics plc to Present at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference  
2/8/2012 10:16:53 AM

Oxford and Newcastle, UK, 8 February 2012 - Drug discovery and development company e-Therapeutics plc (AIM: ETX) announces that its CFO, Dr Daniel Elger, will present an overview of the Company’s strategy, platform and clinical development programmes at the 14th Annual BIO CEO & Investor Conference in New York on Monday 13 February at 2.00 pm EST (1900 BST).

A webcast of the presentation will be available on e-Therapeutics’ website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

About e-Therapeutics

e-Therapeutics is an AIM-listed biotechnology company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on advances in network science and chemical biology. The Company’s discovery activity is focused in cancer and degenerative diseases of the nervous system and its development effort on four clinical candidates spanning cancer, psychiatric disorders and infectious diseases. e-Therapeutics is based at sites in Oxford and Newcastle, UK. For more information about the Company please visit


e-Therapeutics plc

Malcolm Young / Daniel Elger

Tel: +44 (0) 7909 915 068

Panmure Gordon (UK) Limited

Andrew Burnett / Fred Walsh

Tel: +44 (0) 20 7459 3600

College Hill

Melanie Toyne Sewell / Jayne Crook

Tel: +44 (0) 20 7457 2020


CommStrat Group (US)

Ted Agne

Tel: (+1) 781 631 3117